Comparison of colorectal neoplastic polyps and adenocarcinoma with regard to NLR and PLR

European Review for Medical and Pharmacological Sciences

Volumn 19, Issue 19, 2015, Pages 3613-3618

  Emir, S ^a   Aydin, M ^a   Can, G ^b   Bali, I ^a   Yildirim, O ^a   Oznur M ^a   Yildiz, Z D ^a   Sozen S ^a   Gurel A ^a  

^a NAMIK KEMAL UNIVERSITY   (Turkey)

^b Hayrabolu State Hospital   (Turkey)

Author keywords

Biomarker; Colorectal cancer; Neutrophil lymphocyte ratio; Platelet lymphocyte ratio

Indexed keywords

BIOLOGICAL MARKER; TUMOR MARKER;

ADENOMATOUS POLYP; ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD CELL RATIO; CANCER PATIENT; COLORECTAL CANCER; COLORECTAL NEOPLASTIC POLYP; COLORECTAL POLYP; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; LEUKOCYTE COUNT; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL COUNT; NEUTROPHIL LEUKOCYTE RATIO; PLATELET LYMPHOCYTE RATIO; SENSITIVITY AND SPECIFICITY; THROMBOCYTE COUNT; VILLOUS ADENOMA; ADENOCARCINOMA; BLOOD; COLONIC POLYPS; COLORECTAL NEOPLASMS; COMPARATIVE STUDY; LEUKOCYTE; LYMPHOCYTE; METABOLISM; MIDDLE AGED; NEUTROPHIL; PATHOLOGY; RETROSPECTIVE STUDY; THROMBOCYTE; VERY ELDERLY; YOUNG ADULT;

ADENOCARCINOMA; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOMARKERS, TUMOR; BLOOD PLATELETS; COLONIC POLYPS; COLORECTAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; LEUKOCYTES; LYMPHOCYTES; MALE; MIDDLE AGED; NEUTROPHILS; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84966293247     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. SIEGEL R, DESANTIS C, JEMAL A. Colorectal cancer statistics. CA Cancer J Clin 2014; 64: 104-117.
2. KONISHI F, MORSON BC. Pathology of colorectal adenomas: A colonoscopic survey. J ClinPathol 1982; 35: 830-41.
3. MANTOVANI A, ALLAVENA P, SICA A, BALKWILL F. Cancer-related inflammation. Nature 2008; 454: 436-444.
4. FOLSOM AR, ROSAMOND WD, SHAHAR E, COOPER S, ALEKSIC N, NIETO FJ, RASMUSSEN ML, WU KK. Prospective studyof markers of hemostatic function with risk of ischemic stroke. the atherosclerosis risk in communities (ARIC) study investigators. Circulation 1999; 100: 736-742.
5. FOLSOM AR, ALEKSIC N, CATELLIER D, JUNEJA HS, WU KK. C-reactive protein and incident coronary heart disease in the atherosclerosis risk in communities (ARIC) study. Am Heart J 2002; 144: 233-238.
6. YALCINKAYA E, BUGAN B, CELIK M, YASAR S, GURSOY E. Neutrophil lymphocyte ratio should be assessed together with other inflammatory markers and confounding factors. Eur Rev Med Pharmacol Sci 2013; 17: 2410.
7. PAIK KY, LEE IK, LEE YS, SUNG NY, KWONTS. Clinical implications of systemic inflammatory response markers as independentprognostic factors in colorectal cancer patients. Cancer Res Treat 2014; 46: 65-73.
8. HALAZUN KJ, ALDOORI A, MALIK HZ, AL-MUKHTAR A, PRASAD KR, TOOGOOD GJ, LODGEJP. Elevated Preoperative neutrophil to lymphocyte ratio predicts survival following hepatic resection for colorectal liver metastases. Eur J Surg Oncol 2008; 34: 55-60.
9. DING PR, AN X, ZHANG RX, FANG YJ, LI LR, CHEN G, WU XJ, LU ZH, LIN JZ, KONG LH, WAN DS, PAN ZZ. Elevated preoperative neutrophil to lymphocyte ratio predicts risk of recurrence following curative resection for stage IIA coloncancer. Int J Colorectal Dis 2010; 25: 1427-1433.
10. KLINGER MH, JELKMANN W. Role of blood platelets in infection and inflammation. J Interferon Cytokine Res 2002; 22: 913-922.
11. IKEDA M, FURUKAWA H, IMAMURA H, SHIMIZU J, ISHIDA H, MASUTANI S, TATSUTA M, SATOMI T. Poor prognosis associated with thrombocytosis in patients with gastric cancer. Ann Surg Oncol 2002; 9: 287-291.
12. BALTA S, DEMIRKOL S, CELIK T, KUCUK U, UNLU M, ARSLAN Z, BALTA I, IYISOY A, KOCAK N, HAQMAL H, YOKUSOGLU M. Association between coronary artery ectasia and neutrophil-lymphocyte ratio. Angiology 2013; 64: 627-632.
13. BALTA S, DEMIRKOL S, UNLU M, KUCUK U, ARSLAN Z. Mean platelet volume in patients with ischemic stroke. Eur Rev Med Pharmacol Sci 2013; 17: 3121-3122.
14. BHATTI I, PEACOCK O, LLOYD G, LARVIN M, HALL RI. Preoperative hematologic markers as independent predictors of prognosis in resected pancreatic ductal adenocarcinoma: neutrophil-lymphocyte versus platelet-lymphocyte ratio. Am J Surg 2010; 200: 197-203.
15. FENOGLIO CM, PASCAL RR. Colorectal adenomas and cancer: Pathologic relationships. Cancer 1982; 50: 2601-2608.
16. COMPTON CC. Colorectal carcinoma: diagnostic, prognostic, and molecular features. Mod Pathol 2003; 16: 376-388.
17. O'CONNELL JB, MAGGARD MA, KO CY. Colon cance rsurvival rates with the new AJCC sixth edition staging. JNCI 2004; 96: 1420-1424.
18. BALKWILL F, MANTOVANI A. Inflammation and cancer: back to Virchow? Lancet 2001; 357(9255): 539-545.
19. LORD BI, BRONCHUD MH, OWENS S, CHAN GJ, HOWELL A, SOUZA L, DEXTER TM. The kinetics of human granulopoiesis following treatment with granulocyte colony-stimulating factor in vivo. Proc Natl Acad Sci USA 1989; 86: 9499-9503.
20. ULICH TR, DEL CASTILLO J, WATSON LR, YIN SM, GARNICK MB. In vivo hematologic effects of recombinant human macrophage colony-stimulating factor. Blood 1990; 75: 846-850.
21. AGLIETTA M, PIACIBELLO W, SANAVIO F, STACCHINI A, APRA F, SCHENA M, MOSSETTI C, CARNINO F, CALIGARISCAPPIO F, GAVOSTO F. Kinetics of human hemopoietic cells after in vivo administration of granulocytemacrophage colony-stimulating factor. J Clin Invest 1989; 83: 551-557.
22. PRICE TH, CHATTA GS, DALE DC. Effect of recombinant granulocyte colony stimulating factor on neutrophil kinetics in normal young and elderly humans. Blood 1996; 88: 335-340.
23. DE LARCO JE, WUERTZ BR, FURCHT LT. Thepotential role of neutrophils in promoting the metastatic phenotype of tumors releasing interleukin-8. Clin Cancer Res 2004; 10: 4895-4900.
24. RODRIGUEZ PC, ERNSTOFF MS, HERNANDEZ C, ATKINS M, ZABALETA J, SIERRA R, OCHOA AC. Arginase Iproducingmyeloid-derived suppressor cells in renal cell carcinoma are a subpopulation of activated granulocytes. CancerRes 2009; 69: 1553-1560.
25. MULLER I, MUNDER M, KROPF P, HANSCH GM. Polymorphonuclear neutrophils and T lymphocytes: strange bed fellows or brothers in arms? Trends Immunol 2009; 30: 522-530.
26. PETRIE HT, KLASSEN LW, KAY HD. Inhibition of human Cytotoxic T lymphocyte activity in vitro By autologous peripheral blood granulocytes. J Immunol 1985; 134: 230-234.
27. KLINGER MH, JELKMANN W. Role of blood platelets in infection and inflammation. J Interferon Cytokine Res 2002; 22: 913-922.
28. BHATTI I, PEACOCK O, LLOYD G, LARVIN M, HALL RI. Preoperative hematologic markers as independent predictors of prognosis in resected pancreatic ductal adenocarcinoma: neutrophil-lymphocyte versus platelet lymphocyte ratio. Am J Surg 2010; 200: 197-203.
29. KUSUMANTO YH, DAM WA, HOSPERS GA, MEIJER C, MULDER NH. Platelets and granulocytes, in particular the neutrophils, form important compartments for circulating vascular endothelial growth factor. Angiogenesis 2003; 6: 283-287.
30. KLINGER MH, JELKMANN W. Role of blood platelets in infection and inflammation. J Interferon Cytokine Res 2002; 22: 913-922.
31. DUNN GP, OLD LJ, SCHREIBER RD. Theimmunobiology of cancer immuno surveillance and immuno editing. Immunity 2004; 21: 137-148.
32. DESCHOOLMEESTER V, BAAY M, VAN MARCK E, WEYLER J, VERMEULEN P, LARDON F, VERMORKEN JB. Tumor infiltrating lymphocytes: an intriguing player in the survival of colorectal cancer patients. BMC Immunol 2010; 11: 19.
33. GÖKHAN S, ÖZHASENEKLER A, MANSUR DURGUN H, AKIL E, USTÜNDAG M, ORAK M. Neutrophil lymphocyte ratios in stroke subtypes and transient ischemic attack. Eur Rev Med Pharmacol Sci 2013; 17: 653-657.
34. KARAMAN H, KARAMAN A, ERDEN A, POYRAZOGLU OK, KARAKUKCU C, TASDEMIR A. Relationship between colonic polyp type and the neutrophil/lymphocyte ratio as a biomarker. Asian Pac J Cancer Prev 2013; 14: 3159-3161.
35. WALSH SR, COOK EJ, GOULDER F, JUSTIN TA, KEELING NJ. Neutrophil-lymphocyte ratio as a prognostic factor in colorectal cancer. J Surg Oncol 2005; 91: 181-184.
36. HE W, YIN C, GUO G, JIANG C, WANG F, QIU H, CHEN X, RONG R, ZHANG B, XIA L. Initial neutrophil lymphocyte ratio is superior to platelet lymphocyte ratio as an adverse prognostic and predictive factor in metastatic colorectal cancer.Med Oncol 2013; 30: 439.
37. KARAMAN H, KARAMAN A, ERDEN A, POYRAZOGLU OK, KARAKUKCU C, TASDEMIR A. Relationship between colonic polyp type and the neutrophil/lymphocyte ratio as a biomarker. Asian Pacific J Cancer Prev 2013; 14: 3159-3161.
38. RAUNGKAEWMANEE S, TANGJITGAMOL S, MANUSIRIVITHAYA S, SRIJAIPRACHAROEN S, THAVARAMARA T. Platelet to lymphocyte ratio as a prognostic factor for epithelial ovarian cancer. J Gynecol Oncol 2012; 23: 265-273.
39. ASHER V, LEE J, INNAMAA A, BALI A. Preoperative platelet lymphocyte ratio as an independent prognostic marker in ovarian cancer. Clin Trans Oncol 2011; 13: 499-503.
40. SMITH RA, BOSONNET L, RARATY M, SUTTON R, NEOPTOLEMOS JP, CAMPBELL F, GHANEH P. Preoperative platelet lymphocyte ratio is an independent significant prognostic marker in resected pancreatic ductal adenocarcinoma. Am J Surg 2009; 197: 466-472.
41. KWON HC, KIM SH, OH SY, LEE S, LEE JH, CHOI HJ, PARK KJ, ROH MS, KIM SG, KIM HJ, LEE JH. Clinical significance of preoperative neutrophil-lymphocyte versus platelet-lymphocyte ratio in patients with operable colorectal cancer. Biomarkers 2012; 17: 216-222.
42. LIU H, DU X, SUN P, XIAO C, XU Y, LI R. Preoperative platelet-lymphocyte ratio is an independent prognostic factor for resectable colorectal cancer. Nan Fang Yi Ke Da Xue Xue Bao 2013; 33: 70-73.